George A. Freeman - Concepedia

Concepedia

Author

George A. Freeman

Research Triangle Park Foundation

Also Known As

G A Freeman, G. A. FREEMAN, G. A. Freeman, G. Andrew Freeman, G.A Freeman, G.A. Freeman, G.Andrew Freeman, George A. Freeman

38

Publications

2.4K

Citations

17

H-Index

30

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Burroughs Wellcome Fund University of Michigan University of Oxford

GA

About

George A. Freeman is an author at Research Triangle Park Foundation specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1.9K
2	Natural Sciences	6	6	1.6K
3	Biochemistry	5	5	1.6K
4	Biomolecular Engineering	5	5	205
5	Engineering	2	2	47

George A. Freeman

×

21

Publications

2.4K

Citations

17

H-Index

	Year	Citations
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase. P A Furman, James A. Fyfe, M H St Clair, Proceedings of the National Academy of Sciences Viral ReplicationThymidine AnalogImmunologyMolecular BiologyAntiviral Drug	1986	1.3K
Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor Karen R. Romines, George A. Freeman, Lee T. Schaller, Journal of Medicinal Chemistry	2005	167
Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U) Lynn P. Elwell, Robert Ferone, George A. Freeman, Antimicrobial Agents and Chemotherapy Thymidine AnalogBioorganic ChemistryMicrobial PathogensAntibacterial ActivityEscherichia Coli	1987	158
Synthesis and Antiviral Activity of 2‘-Deoxy-4‘-thio Purine Nucleosides Nanine A. Van Draanen, George A. Freeman, Steven A. Short, Journal of Medicinal Chemistry Medicinal ChemistryHbv ReplicationAntiviral ActivityMedicineImmunology	1996	70
Novel Benzophenones as Non-nucleoside Reverse Transcriptase Inhibitors of HIV-1 Joseph H. Chan, George A. Freeman, Jeffrey H. Tidwell, Journal of Medicinal Chemistry	2004	64
Design of Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase with Improved Drug Resistance Properties. 2. George A. Freeman, C. Webster Andrews, Andrew L. Hopkins, Journal of Medicinal Chemistry Molecular BiologyPharmacotherapyAntiviral DrugDrug ResistanceMedicinal Chemistry	2004	62
Antiviral Activity of GW678248, a Novel Benzophenone Nonnucleoside Reverse Transcriptase Inhibitor Robert G. Ferris, Richard Hazen, Grace Roberts, Antimicrobial Agents and Chemotherapy Viral ReplicationImmunologyMolecular BiologyNew GenerationAntiviral Drug	2005	60
Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses Kristjan S. Gudmundsson, Brian A. Johns, Zhicheng Wang, Bioorganic & Medicinal Chemistry MedicineDrug DiscoveryAntiviral Drug DevelopmentAntiviral TherapyVirology	2005	57
Pyrazolopyridine antiherpetics: SAR of C2′ and C7 amine substituents Brian A. Johns, Kristjan S. Gudmundsson, Elizabeth M. Turner, Bioorganic & Medicinal Chemistry Medicinal ChemistryMedicinePyrazolopyridine AntiherpeticsPharmacologyAntiviral Compound	2005	57
3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition. George A. Freeman, Janet L. Rideout, Wayne H. Miller, Journal of Medicinal Chemistry	1992	46

Page 1